MS Highlights from AAN & CMSC

This is a supplement to Neurology Reviews, a member of the MDEdge network. Content includes:

• Initial high-efficacy MS therapy is associated with less disability later  
• Serum NfL in early MS can help predict clinical course 
• No benefit of three commonly used medications for MS fatigue 
• Telerehabilitation may be effective in MS 
• CMSC MRI guidelines evolve into international consensus protocol
• Newest oral DMTs haven’t yet made a big impact in the MS world 

Read the supplement.

This is a supplement to Neurology Reviews, a member of the MDEdge network. Content includes:

• Initial high-efficacy MS therapy is associated with less disability later  
• Serum NfL in early MS can help predict clinical course 
• No benefit of three commonly used medications for MS fatigue 
• Telerehabilitation may be effective in MS 
• CMSC MRI guidelines evolve into international consensus protocol
• Newest oral DMTs haven’t yet made a big impact in the MS world 

Read the supplement.

This is a supplement to Neurology Reviews, a member of the MDEdge network. Content includes:

• Initial high-efficacy MS therapy is associated with less disability later  
• Serum NfL in early MS can help predict clinical course 
• No benefit of three commonly used medications for MS fatigue 
• Telerehabilitation may be effective in MS 
• CMSC MRI guidelines evolve into international consensus protocol
• Newest oral DMTs haven’t yet made a big impact in the MS world 

Read the supplement.